Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Sell
37
AFYA Quote, Financials, Valuation and Earnings
Last price:
$15.97
Seasonality move
:
-4.09%
Day range:
$15.71 - $16.18
52-week range:
$14.52 - $22.24
Dividend yield:
0%
P/E ratio:
13.04x
P/S ratio:
2.42x
P/B ratio:
1.93x
Volume:
118.5K
Avg. volume:
104.2K
1-year change:
-22.13%
Market cap:
$1.5B
Revenue:
$576.2M
EPS (TTM):
$1.24
Analysts' Opinion
-
Consensus RatingAfya has received a consensus rating of Sell. The company's average rating is a Sell based on 1 Buy rating, 2 Hold ratings, and 3 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $19.20, Afya has an estimated upside of 18.86% from its current price of $16.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.92 representing 7.63% downside risk from its current price of $16.15.
Fair Value
-
According to the consensus of 6 analysts, Afya has 18.86% upside to fair value with a price target of $19.20 per share.
AFYA vs. S&P 500
-
Over the past 5 trading days, Afya has underperformed the S&P 500 by -1.58% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Afya does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Afya has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Afya reported revenues of $151.6M.
Earnings Growth
-
Afya has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Afya reported earnings per share of $0.24.
Enterprise value:
1.7B
EV / Invested capital:
--
Price / LTM sales:
2.42x
EV / EBIT:
9.27x
EV / Revenue:
2.77x
PEG ratio (5yr expected):
0.22x
EV / Free cash flow:
10.81x
Price / Operating cash flow:
9.46x
Enterprise value / EBITDA:
6.90x
Gross Profit (TTM):
$385M
Return On Assets:
7.35%
Net Income Margin (TTM):
18.3%
Return On Equity:
15.17%
Return On Invested Capital:
10.16%
Operating Margin:
27.76%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $430.1M | $539.5M | $616.8M | $148.1M | $151.6M | |
| Gross Profit | $272.3M | $330.5M | $385M | $89.1M | $93.2M | |
| Operating Income | $121.2M | $146.4M | $179.2M | $38.8M | $42.1M | |
| EBITDA | $168M | $209.6M | $247.6M | $57.7M | $56.9M | |
| Diluted EPS | $0.75 | $0.78 | $1.24 | $0.21 | $0.24 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $243.1M | $264.6M | $224.8M | $282.5M | $271.6M | |
| Total Assets | $718.5M | $1.2B | $1.3B | $1.6B | $1.6B | |
| Current Liabilities | $101.6M | $121.7M | $180.9M | $239.6M | $170.2M | |
| Total Liabilities | $227.9M | $633.7M | $664.4M | $850.3M | $839.2M | |
| Total Equity | $490.6M | $563.8M | $587.8M | $704.8M | $763.7M | |
| Total Debt | $42M | $267.9M | $271.4M | $389M | $394.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $152.6M | $210.5M | $232.5M | $74.9M | $78.9M | |
| Cash From Investing | -$116.8M | -$219.5M | -$213.1M | -$37.3M | -$108.9M | |
| Cash From Financing | -$96.1M | $26.8M | -$19.6M | -$22.1M | $50M | |
| Free Cash Flow | $92.4M | $156.9M | $158M | $63.8M | $48.1M | |
AFYA
Sector
Market Cap
$1.5B
$420M
Price % of 52-Week High
72.62%
70.04%
Dividend Yield
0%
0%
Shareholder Yield
--
3.75%
1-Year Price Total Return
-22.13%
-14.98%
Beta (5-Year)
0.821
0.943
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$16.56
200-day SMA
Sell
Level
$16.80
Bollinger Bands (100)
Sell
Level
15.62 - 17.16
Chaikin Money Flow
Buy
Level
1.1M
20-day SMA
Sell
Level
$16.97
Relative Strength Index (RSI14)
Sell
Level
43.92
ADX Line
Sell
Level
21.2
Williams %R
Neutral
Level
-73.743
50-day SMA
Sell
Level
$16.28
MACD (12, 26)
Sell
Level
-0.01
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
10.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4489)
Buy
CA Score
(Annual)
Level (0.0124)
Buy
Beneish M-Score
(Annual)
Level (-2.5426)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.1659)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.
Stock Forecast FAQ
In the current month, AFYA has received 1 Buy ratings 2 Hold ratings, and 3 Sell ratings. The AFYA average analyst price target in the past 3 months is $19.20.
-
Where Will Afya Stock Be In 1 Year?
According to analysts, the consensus estimate is that Afya share price will rise to $19.20 per share over the next 12 months.
-
What Do Analysts Say About Afya?
Analysts are divided on their view about Afya share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Afya is a Buy and believe this share price will drop from its current level to $24.82.
-
What Is Afya's Price Target?
The price target for Afya over the next 1-year time period is forecast to be $19.20 according to 6 Wall Street analysts, 1 of them rates the stock a Buy, 3 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is AFYA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Afya is a Sell. 3 of 6 analysts rate the stock a Sell at this time.
-
How Can I Buy Shares Of AFYA?
You can purchase shares of Afya via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Afya shares.
-
What Is The Afya Share Price Today?
Afya was last trading at $15.97 per share. This represents the most recent stock quote for Afya. Yesterday, Afya closed at $16.15 per share.
-
How To Buy Afya Stock Online?
In order to purchase Afya stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Does Intel Stock Have Room to Grow?
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
Is Walmart the Largest Retailer in the World?
For many years, Walmart (NYSE:WMT) has been the world’s largest…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
50
TREE alert for Mar 13
LendingTree [TREE] is up 0.94% over the past day.
Buy
57
INOD alert for Mar 13
Innodata [INOD] is down 7.34% over the past day.
Sell
40
VIST alert for Mar 13
Vista Energy SAB de CV [VIST] is down 0.3% over the past day.
